암의 생물학과 일주기 리듬의 교란
Circadian Rhythm Disruption in Cancer Biology: A Review of Literature
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Circadian rhythm is an oscillating biological rhythm that operates on a 24-hour cycle and is caused by an internal biological clock. Circadian rhythm regulates many physiological processes and behaviors in the human body, and it has been known that disturbance of circadian rhythm causes various diseases including cancer. The interaction between circadian rhythm and cancer appears in both directions, and chronotherapeutics, the concept of treatment according to circadian timing, has become particularly important in these days. In this article, we investigated the definition and physiological-behavioral outputs of circadian rhythm. The circadian rhythm disruption, circadian timing system and chronomodulated chemotherapy were reviewed in relation to cancer biology.
Abstract
Circadian rhythm is an oscillating biological rhythm that operates on a 24-hour cycle and is caused by an internal biological clock. Circadian rhythm regulates many physiological processes and behaviors in the human body, and it has been known that disturbance of circadian rhythm causes various diseases including cancer. The interaction between circadian rhythm and cancer appears in both directions, and chronotherapeutics, the concept of treatment according to circadian timing, has become particularly important in these days. In this article, we investigated the definition and physiological-behavioral outputs of circadian rhythm. The circadian rhythm disruption, circadian timing system and chronomodulated chemotherapy were reviewed in relation to cancer biology.
참고문헌 (99)
- Friedman HS, "Encyclopedia of mental health" (2015), Academic Press
- Pittendrigh CS, "On temperature independence in the clock system controlling emergence time in Drosophila", Proc Natl Acad Sci U S A, 40, pp.1018~ (1954)
- Fu L, "The circadian clock : pacemaker and tumour suppressor", Nat Rev Cancer, 3, pp.350~361 (2003)
- Fu L, "The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo", Cell, 111, pp.41~50 (2002)
- Filipski E, "Host circadian clock as a control point in tumor progression", J Natl Cancer Inst, 94, pp.690~697 (2002)
- Schernhammer ES, "Rotating night shifts and risk of breast cancer in women participating in the nurses’health study", J Natl Cancer Inst, 93, pp.1563~1568 (2001)
- Hansen J, "Increased breast cancer risk among women who work predominantly at night", Epidemiology, 12, pp.74~77 (2001)
- Sulli G, "Interplay between circadian clock and cancer : new frontiers for cancer treatment", Trends Cancer, 5, pp.475~494 (2019)
- Ancoli-Israel S, "Sleep disturbances in cancer : a review", Sleep Med Res, 6, pp.45~49 (2015)
- Carpenter JS, "Circadian rhythm of objectively recorded hot flashes in postmenopausal breast cancer survivors", Menopause, 8, pp.181~188 (2001)
- Lévi F, "Circadian timing in cancer treatments", Annual review of Pharmacology and Toxicology, 50, pp.377~421 (2010)
- Lin HX, "Randomized study of sinusoidal chronomodulated versus flat intermittent induction chemotherapy with cisplatin and 5-fluorouracil followed by traditional radiotherapy for locoregionally advanced nasopharyngeal carcinoma", Chin J Cancer, 32, pp.502~ (2013)
- Vetter C, "Circadian disruption : What do we actually mean", Eur J Neurosci, 51, pp.531~550 (2020)
- Refinetti R, "Circadian rhythmicity of body temperature and metabolism", Temperature, 7, pp.321~362 (2020)
- Fatima N, "Metabolic implications of circadian disruption", Pflugers Arch, 472, pp.513~526 (2020)
- Bray F, "The ever-increasing importance of cancer as a leading cause of premature death worldwide", Cancer, 127, pp.3029~3030 (2021)
- Sung H, "Global cancer statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 71, pp.209~249 (2021)
- Henry DH, "Symptoms and treatment burden associated with cancer treatment : results from a cross-sectional national survey in the US", Support Care Cancer, 16, pp.791~801 (2008)
- Given BA, "Do we have a clue : the treatment burden for the patient with cancer", Cancer Nurs, 39, pp.423~424 (2016)
- Given BA, "The challenge of quality cancer care for family caregivers", Semin Oncol Nurs, 28, pp.205~212 (2012)
- Reppert SM, "Molecular analysis of mammalian circadian rhythms", Annu Rev Physiol, 63, pp.647~676 (2001)
- Reppert SM, "Coordination of circadian timing in mammals", Nature, 418, pp.935~941 (2002)
- Zylka MJ, "Three period homologs in mammals : differential light responses in the suprachiasmatic circadian clock and oscillating transcripts outside of brain", Neuron, 20, pp.1103~1110 (1998)
- Morse D, "No circadian rhythms in testis : Period1expression is clock independent and developmentally regulated in the mouse", Mol Endocrinol, 17, pp.141~151 (2003)
- Czeisler CA, "Stability, precision, and near-24-hour period of the human circadian pacemaker", Science, 284, pp.2177~2181 (1999)
- Kryger MH, "Principles and Practice of Sleep Medicine" (2016), Elsevir
- Kräuchi K, "How is the circadian rhythm of core body temperature regulated", Clin Auton Res, 12, pp.147~149 (2002)
- Gierse A., "Quaenam Sit Ratio Caloris Organici Partium Inflammatione Laborantium Febrium Vaginae in Feminis Menstruis Et Non Menstruis Hominis Dormientis Et Non Dormientis Et Denique Plantarum Investigatur Experimentis Ab Aliis Et a Memet Ipse Institutis", ~ (1842)
- Aschoff J, "A Companion to Animal Physiology", pp.173~188 (1982)
- Waterhouse J, "The circadian rhythm of core temperature : origin and some implications for exercise performance", Chronobiol Int, 22, pp.207~225 (2005)
- Klisch C, "Circadian activity rhythms and phase-shifting of cultured neurons of the rat suprachiasmatic nucleus", Chronobiol Int, 23, pp.181~190 (2006)
- Elkum NB, "Modeling biological rhythms in failure time data", J Circadian Rhythms, 4, pp.1~8 (2006)
- Chiu JC, "Assaying locomotor activity to study circadian rhythms and sleep parameters in Drosophila", J Vis Exp, 43, pp.2157~ (2010)
- Sheldon SH, "Principles and practice of pediatric sleep medicine e-book" (2014), Elsevier Health Sciences
- Klerman EB, "Clinical aspects of human circadian rhythms", J Biol Rhythms, 20, pp.375~386 (2005)
- Lewy AJ, "Analysis of melatonin in human plasma by gas chromatography negative chemical ionization mass spectrometry", Science, 201, pp.741~743 (1978)
- Lewy AJ, "Effects of light on human melatonin production and the human circadian system", Prog Neuropsychopharmacol Biol Psychiatry, 7, pp.551~556 (1983)
- Lockley SW, "Melatonin administration can entrain the freerunning circadian system of blind subjects", J Endocrinol, 164, pp.R1~6 (2000)
- Lewy AJ, "The human phase response curve(PRC)to melatonin is about 12 hours out of phase with the PRC to light", Chronobiol Int, 15, pp.71~83 (1998)
- Bhake R, "Continuous free cortisol profiles-circadian rhythms in healthy men", J Clin Endocrinol Metab, 104, pp.5935~5947 (2019)
- Mohd Azmi NAS, "Cortisol on circadian rhythm and its effect on cardiovascular system", Int J Environ Res Public Health, 18, pp.676~ (2021)
- de Weerth C, "Development of cortisol circadian rhythm in infancy", Early Hum Dev, 73, pp.39~52 (2003)
- Scher A, "Sleep quality, cortisol levels, and behavioral regulation in toddlers", Dev Psychobiol, 52, pp.44~53 (2010)
- Evanson NK, "Nongenomic actions of adrenal steroids in the central nervous system", J Neuroendocrinol, 22, pp.846~861 (2010)
- Oshima T, "Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer", Oncol Rep, 25, pp.1439~1446 (2011)
- King DP, "Positional cloning of the mouse circadian clock gene", Cell, 89, pp.641~653 (1997)
- Takano A, "Cloning and characterization of rat casein kinase 1epsilon", FEBS Lett, 477, pp.106~112 (2000)
- Ralph MR, "A mutation of the circadian system in golden hamsters", Science, 241, pp.1225~1227 (1988)
- Hsu DS, "Putative human blue-light photoreceptors hCRY1 and hCRY2 are flavoproteins", Biochemistry, 35, pp.13871~13877 (1996)
- van der Spek P, "Cloning, tissue expression, and mapping of a human photolyase homolog with similarity to plant blue-light receptors", Genomics, 37, pp.177~182 (1996)
- Thresher RJ, "Role of mouse cryptochrome blue-light photoreceptor in circadian photoresponses", Science, 282, pp.1490~1494 (1998)
- Albrecht U, "A differential response of two putative mammalian circadian regulators, mper1and mper2, to light", Cell, 91, pp.1055~1064 (1997)
- Sun ZS, "RIGUI, a putative mammalian ortholog of the Drosophila period gene", Cell, 90, pp.1003~1011 (1997)
- Tei H, "Circadian oscillation of a mammalian homologue of the Drosophila period gene", Nature, 389, pp.512~516 (1997)
- Takumi T, "A light-independent oscillatory gene mPer3 in mouse SCN and OVLT", EMBO J, 17, pp.4753~4759 (1998)
- Hogenesch JB, "The basichelix–loop–helix-PAS orphan MOP3 forms transcriptionally active complexes with circadian and hypoxia factors", Proc Natl Acad Sci U S A, 95, pp.5474~5479 (1998)
- Honma S, "Circadian oscillation of BMAL1, a partner of a mammalian clock geneclock, in rat suprachiasmatic nucleus", Biochem Biophys Res Commun, 250, pp.83~87 (1998)
- Shearman LP, "Interacting molecular loops in the mammalian circadian clock", Science, 288, pp.1013~1019 (2000)
- Nakahata Y, "Signaling to the circadian clock : plasticity by chromatin remodeling", Curr Opin Cell Biol, 19, pp.230~237 (2007)
- Preitner N, "The orphan nuclear receptor REV-ERBαcontrols circadian transcription within the positive limb of the mammalian circadian oscillator", Cell, 110, pp.251~260 (2002)
- Etchegaray JP, "Rhythmic histone acetylation underlies transcription in the mammalian circadian clock", Nature, 421, pp.177~182 (2003)
- Mormont MC, "Marker rhythms of circadian system function : a study of patients with metastatic colorectal cancer and good performance status", Chronobiol Int, 19, pp.141~155 (2002)
- Stephan FK, "Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions", Proc Natl Acad Sci U S A, 69, pp.1583~1586 (1972)
- Liu C, "Cellular construction of a circadian clock : period determination in the suprachiasmatic nuclei", Cell, 91, pp.855~860 (1997)
- Momma T, "Expression of circadian clock genes in human colorectal adenoma and carcinoma", Oncology Letters, 14, pp.5319~5325 (2017)
- Mormont MC, "Circadian-system alterations during cancer processes : a review", Int J Cancer, 70, pp.241~247 (1997)
- Bartsch C, "Evidence for modulation of melatonin secretion in men with benign and malignant tumors of the prostate : relationship with the pituitary hormones", J Pineal Res, 2, pp.121~132 (1985)
- Bartsch C, "Diminished pineal function coincides with disturbed circadian endocrine rhythmicity in untreated primary cancer patients : consequence of premature aging or of tumor growth", Ann N Y Acad Sci, 719, pp.502~525 (1994)
- Tamarkin L, "Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer", Science, 216, pp.1003~1005 (1982)
- Bartsch C, "Stage-dependent depression of melatonin in patients with primary breast cancer. Correlation with prolactin, thyroid stimulating hormone, and steroid receptors", Cancer, 64, pp.426~433 (1989)
- Touitou Y, "Rhythm alteration in patients with metastatic breast cancer and poor prognostic factors", J Cancer Res Clin Oncol, 121, pp.181~188 (1995)
- Touitou Y, "Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients : relationships with tumour marker antigens", Br J Cancer, 74, pp.1248~1252 (1996)
- Benavides Orgaz M, "Cancer avance de l’ovaire: approche chronobiologique comme nouvelle strategie du traitement et de la surveillance clinique et biologique", Paris 11, ~ (1991)
- Richter HG, "The circadian timing system : making sense of day", night gene expression, 2004, pp.37, 11~28
- Hastings MH, "A clockwork web: circadian timing in brain and periphery, in health and disease", Nat Rev Neurosci, 4, pp.649~661 (2003)
- Touitou Y, "Biologic rhythms in clinical and laboratory medicine" (2012), Springer Science & Business Media
- Lévi F, "Circadian rhythms : mechanisms and therapeutic implications", Annu Rev Pharmacol Toxicol, 47, pp.593~628 (2007)
- Lévi F, "Cold Spring Harbor symposia on quantitative biology", pp.465~475 (2007), Cold Spring Harbor Laboratory Press
- Roenneberg T, "Entrainment of the human circadian clock", Cold Spring Harb Symp Quant Biol, 72, pp.293~299 (2007)
- Takahashi JS, "The genetics of mammalian circadian order and disorder : implications for physiology and disease", Nat Rev Genet, 9, pp.764~ (2008)
- Ohdo S, "Changing the dosing schedule minimizes the disruptive effects of interferon on clock function", Nat Med, 7, pp.356~360 (2001)
- Iurisci I, "Liver circadian clock, a pharmacologic target of cyclin-dependent kinase inhibitor seliciclib", Chronobiol Int, 26, pp.1169~1188 (2009)
- Li XM, "Pharmacological effects of vinorelbine on body temperature and locomotor activity circadian rhythms in mice", Chronobiol Int, 19, pp.43~55 (2002)
- Li X, "Circadian physiology is a toxicity target of the anticancer drug gemcitabine in mice", J Biol Rhythms, 22, pp.159~166 (2007)
- DeVita VT, "DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology" (2008), Lippincott Williams & Wilkins
- Rowland M, "Clinical pharmacokinetics: concepts and applications" (1994), Lippincott Williams & Wilkins
- Zhang YKJ, "Circadian expression profiles of drug-processing genes and transcription factors in mouse liver", Drug Metab Dispos, 37, pp.106~115 (2009)
- Terazono H, "Modulatory effects of 5-fluorouracil on the rhythmic expression of circadian clock genes : a possible mechanism of chemotherapy-induced circadian rhythm disturbances", Biochem Pharmacol, 75, pp.1616~1622 (2008)
- Terazono H, "Modulatory effects of 5-fluorouracil on the rhythmic expression of circadian clock genes : a possible mechanism of chemotherapy-induced circadian rhythm disturbances", Biochem Pharmacol, 75, pp.1616~1622 (2008)
- Liao C, "Chronomodulated chemotherapy versus conventional chemotherapy for advanced colorectal cancer: a meta-analysis of five randomized controlled trials", Int J Colorectal Dis, 25, pp.343~350 (2010)
- Hrushesky W, "A recent illustration of some essentials of circadian chronotherapy study design", J Clin Oncol, 22, pp.2971~2972 (2004)
- Garufi C, "Randomised phase II study of standard versus chronomodulated CPT-11 plus chronomodulated 5-fluorouracil and folinic acid in advanced colorectal cancer patients", Eur J Cancer, 42, pp.608~616 (2006)
- Rivard GE, "Maintenance chemotherapy for childhood acute lymphoblastic leukaemia : better in the evening", Lancet, 2, pp.1264~1266 (1985)
- Altinok A, "A cell cycle automaton model for probing circadian patterns of anticancer drug delivery", Adv Drug Deliv Rev, 59, pp.1036~1053 (2007)
- Lévi F, "Implications of circadian clocks for the rhythmic delivery of cancer therapeutics", Philos Transact A Math Phys Eng Sci, 366, pp.3575~3598 (2008)
- Huang Y, "Efficacy and safety of chronomodulated chemotherapy for patients with metastatic colorectal cancer : a systemat review and meta-analysis", Asia Pac J Clin Oncol, 13, pp.e171~e178 (2017)
- Baraldo M, "The influence of circadian rhythms on the kinetics of drugs in humans", Expert Opin Drug Metab Toxicol, 4, pp.175~192 (2008)
- Boughattas NA, "Stable circadian mechanisms of toxicity of two platinum analogs(cisplatin and carboplatin)despite repeated dosages in mice", J Pharmacol Exp Ther, 255, pp.672~679 (1990)
- Tampellini M, "Circadian variation of vinorelbine toxicity in mice", Chronobiology International, 12, pp.195~198 (1995)
